, Volume 35, Supplement 5, pp 59–61 | Cite as

Effects of Antihypertensive Therapy on Kidney Function in Diabetic Patients

  • Bengt Scherstén
Section 2: The Pathogenic Role of the Kidney


Diabetic nephropathy is one of the major long term complications responsible for mortality in diabetes mellitus. While strict metabolic control of diabetes probably has a positive influence on kidney disease, most evidence supports the view that the process leading to end-stage renal failure has become independent of the metabolic disturbances of diabetes, and that haemodynamic factors in established nephropathy have become the predominant causes of progression of renal damage. In particular, increased intraglomerular pressure is thought to play a crucial part in the development of diabetic nephropathy. Therefore, drugs that can reduce intraglomerular pressure are of interest in treatment of hypertension in diabetic patients. The angiotensin-converting enzyme (ACE) inhibitors have been shown to reduce intraglomerular pressure in animal studies, and the use of these drugs to treat insulin-dependent diabetics with hypertension has produced a reduction in the rate of decline of glomerular filtration rate. Although some β-blockers can also have beneficial effects on renal function, they may produce unwanted metabolic effects. Thus the ACE inhibitors seem to be the most suitable antihypertensive drugs for diabetic patients.


Diabetic Nephropathy Renal Plasma Flow Intraglomerular Pressure Diabetic Nephro Elevated Arterial Blood Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501, 1983PubMedCrossRefGoogle Scholar
  2. Anderson S, Brenner BM. The role of intraglomerular pressure in the initiation and progression of renal disease. Journal of Hypertension 4 (Suppl. 5): S236–S238, 1986PubMedGoogle Scholar
  3. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. Journal of Clinical Investigation 76: 612–619, 1985PubMedCrossRefGoogle Scholar
  4. Bauer JH. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. American Journal of Medicine 77 (Suppl. 2A): 43–51, 1984PubMedGoogle Scholar
  5. Bauer JH, Gaddy P. Effects of enalapril alone, and in combination with hydrochlorothiazide, on renin-angiotensin-aldosterone, renal function, salt and water excretion, and body fluid composition. American Journal of Kidney Diseases 6: 222–232, 1985PubMedGoogle Scholar
  6. Bauer JH, Reams G. Renal effects of angiotensin converting enzyme inhibitors in hypertension. American Journal of Medicine 81 (Suppl. 4C): 19–27, 1986PubMedCrossRefGoogle Scholar
  7. Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, et al. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. British Medical Journal 293: 471–474, 1986PubMedCrossRefGoogle Scholar
  8. Brenner BM. Nephron adaptation renal injury or ablation. American Journal of Physiology 249: 324–337, 1985Google Scholar
  9. Connell JMC. Treating the diabetic hypertensive. ACE Report SBJ 87-R-911-G(34): 1–6, 1987Google Scholar
  10. Drury PL. Diabetes and arterial hypertension. Diabetologia 24: 2–9, 1983CrossRefGoogle Scholar
  11. Drury PL, Smith GM, Ferriss JB. Increased vasopressor responsiveness to angiotensin II in type I (insulin-dependent) diabetic patients without complications. Diabetologia 27: 174–179, 1984PubMedGoogle Scholar
  12. Hommel E, Parving H-H, Mathieson E, Edsberg B, Damkjaer M, et al. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. British Medical Journal 293: 467–470, 1986PubMedCrossRefGoogle Scholar
  13. Jackson B, Debrevi L, Whitty M, Johnston CI. Progression of renal disease: effects of different classes of antihypertensive therapy. Journal of Hypertension 4 (Suppl. 5): S269–S271, 1986Google Scholar
  14. Kaplan NM, Rosenstock J, Raskin P. A differing view of treatment of hypertension in patients with diabetes mellitus. Archives of Internal Medicine 147: 1160–1162, 1987PubMedCrossRefGoogle Scholar
  15. Knowler WC. Magnitude of the renal failure problem in diabetes. Kidney International 6: 2–7, 1974Google Scholar
  16. Mogensen CE, Steffes MW, Dechert T, Christiansen JS. Functional and morphological renal manifestations in diabetes mellitus. Diabetologia 21: 89–93, 1981PubMedCrossRefGoogle Scholar
  17. Parving H-H, Christiansen JS, Noer I, Frouier B, Mogensen CE. The effect of glucagon infusion on kidney function in shortterm insulin-dependent juvenile diabetes. Diabetologia 19: 350–354, 1980PubMedCrossRefGoogle Scholar
  18. Parving H-H, Anderson AR, Hommel E, Smidt U. Effects of longterm antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension 7 (Suppl. II): 114–117, 1985aGoogle Scholar
  19. Parving H-H, Andersen AR, Hommel E, Smidt U. Effect of longterm antihypertensive treatment of kidney function in diabetic nephropathy. Hypertension 7 (Suppl. II): 114–117, 1985bGoogle Scholar
  20. Simon G, Morioka S, Snyder DK, Cohn JN. Increased renal plasma flow in long-term enalapril treatment of hypertension. Clinical Pharmacology and Therapeutics 34: 459–65, 1983PubMedCrossRefGoogle Scholar
  21. Wiseman MJ, Saunders AJ, Keen H, Viberti G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. New England Journal of Medicine 312: 617–21, 1985PubMedCrossRefGoogle Scholar
  22. The Working Group on Hypertension in Diabetes. Statement of hypertension in diabetes mellitus. Archives of Internal Medicine 147: 830–842, 1987CrossRefGoogle Scholar

Copyright information

© ADIS Press Limited 1988

Authors and Affiliations

  • Bengt Scherstén
    • 1
  1. 1.Department of Community Health SciencesLund University Health Sciences Centre, VårdcentralenDalbySweden

Personalised recommendations